Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-04

Clinical Trial Update: Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure [NA]

View source ↗

Summary

An update on an ongoing clinical trial evaluating RELiZORB for treating feeding intolerance in critically ill adults with multi-organ failure; recruitment is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RELiZORB

Snippet

Sponsor: Inova Health Care Services | Conditions: Multi Organ Failure, Exocrine Pancreatic Insufficiency | NA | Status: RECRUITING